Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
ONCOLOGY RESEARCH AND TREATMENT
Journal
Overview
Identity
View All
Overview
publication venue for
Final analysis results from TITAN: A phase 3 study of apalutamide (APA) vs placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving adrogen deprivation therapy (ADT)
2021
TITAN, a phase 3 study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT)
2019
Identity
International Standard Serial Number (ISSN)
2296-5270
Electronic International Standard Serial Number (EISSN)
2296-5262
